Dados B3 › BRST3 × OIBR3
BRST3 × OIBR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BRST3 | OIBR3 | year |
|---|---|---|---|
| ROE | 2.7% | -243.5% | no year where both have it (2025 × 2021) |
| ROIC | 7.1% | -91.3%! | no year where both have it (2025 × 2022) |
| ROA | 1.7% | 41.9%! | 2024 |
| Gross margin | 42.1% | -45.7%! | 2024 |
| EBIT margin | 13.5% | -61.5%! | 2024 |
| Net margin | 4.3% | 302.2%! | 2024 |
| Net debt/EBITDA | 2.20x | 11.73x | no year where both have it (2025 × 2021) |
| Current ratio | 1.12x | 1.00x! | 2024 |
| Revenue growth (1y) | 16.3% | -25.3%! | 2024 |
| Revenue growth (5y CAGR) | — | -21.2%! | no year where both have it |
| Piotroski F-Score | 4/9 | 5/9! | 2024 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BRST3 | OIBR3 | year |
|---|---|---|---|
| P/E | 31.85x | 0.00x | 2025 × 2024 |
| P/B | 0.84x | — | 2025 × 2024 |
| EV/EBITDA | 3.94x | — | 2025 × 2024 |
| FCF yield | -18.2% | -352,559.1% | 2025 × 2024 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:30 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:30 UTC. If this does not match /saude, you are reading a cached copy.